HPR181 Comprehensive and Standardized Value Assessment of Innovative Cancer Treatments: A Multi-Criteria Decision Analysis (MCDA) Tool for Switzerland
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1499
https://www.valueinhealthjournal.com/article/S1098-3015(23)04629-6/fulltext
Title :
HPR181 Comprehensive and Standardized Value Assessment of Innovative Cancer Treatments: A Multi-Criteria Decision Analysis (MCDA) Tool for Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04629-6&doi=10.1016/j.jval.2023.09.1499
First page :
Section Title :
Open access? :
No
Section Order :
10950